- Public Comps
- Giunti Psychometrics
Giunti Psychometrics Valuation Multiples
Discover revenue and EBITDA valuation multiples for Giunti Psychometrics and similar public comparables like FamiCord, Concord Medical, Medcorp, Hyperfine and more.
Giunti Psychometrics Overview
About Giunti Psychometrics
Giunti Psychometrics Holding SpA operates internationally in the field of psychological assessment. The company designs, develops, and distributes tools and methodologies for psychologicaland psycho-aptitude assessment, used in various fields, including clinical practice (clinical and health psychology, child psychiatry and neuropsychiatry, neuropsychology and speech therapy), human resources management (work and organizational psychology), and education and guidance (level assessment tests, tools for diagnosing learning difficulties, and tools for school, university, and career guidance). The majority of revenue is derived from sales in the mental health and clinical area.
Founded
1950
HQ

Employees
N/A
Website
Sectors
Financials (FY)
EV
$71M
Valuation Multiples
Start free trialGiunti Psychometrics Financials
Giunti Psychometrics reported last fiscal year revenue of $44M and EBITDA of $7M.
In the same fiscal year, Giunti Psychometrics generated $36M in gross profit, $7M in EBITDA, and $2M in net income.
Giunti Psychometrics P&L
In the most recent fiscal year, Giunti Psychometrics reported revenue of $44M and EBITDA of $7M.
Giunti Psychometrics is profitable as of last fiscal year, with gross margin of 81%, EBITDA margin of 17%, and net margin of 4%.
Financial data powered by Morningstar, Inc.
Giunti Psychometrics Stock Performance
Giunti Psychometrics has current market cap of $62M, and enterprise value of $71M.
Giunti Psychometrics' stock price is $5.21.
Giunti Psychometrics has an EPS (earnings per share) of $0.16.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $71M | $62M | -0.3% | - | - | - | $0.16 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGiunti Psychometrics Valuation Multiples
Giunti Psychometrics trades at 1.6x EV/Revenue multiple, and 9.5x EV/EBITDA.
Giunti Psychometrics Financial Valuation Multiples
As of September 1, 2026, Giunti Psychometrics has market cap of $62M and EV of $71M.
Giunti Psychometrics has a P/E ratio of 33.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Giunti Psychometrics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Giunti Psychometrics Margins & Growth Rates
In the most recent fiscal year, Giunti Psychometrics reported gross margin of 81%, EBITDA margin of 17%, and net margin of 4%.
Giunti Psychometrics Margins
Giunti Psychometrics Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Giunti Psychometrics Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Giunti Psychometrics Competitors
Giunti Psychometrics competitors include FamiCord, Concord Medical, Medcorp, Hyperfine, Sudmedica, Clinica de Marly, Emyria, EuroEyes Eye Clinic, Gesundheitswelt Chiemgau and Maternus-Kliniken.
Most Giunti Psychometrics public comparables operate across Hospitals & Clinics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.7x | 0.7x | 11.7x | 6.1x | |||
| 7.8x | - | (105.8x) | - | |||
| - | - | - | - | |||
| 4.2x | 3.2x | (1.6x) | (1.8x) | |||
| 215.4x | - | (122.5x) | - | |||
| - | - | - | - | |||
| 20.1x | 5.1x | (10.5x) | (5.0x) | |||
| 0.7x | - | 2.3x | - | |||
This data is available for Pro users. Sign up to see all Giunti Psychometrics competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Giunti Psychometrics
| When was Giunti Psychometrics founded? | Giunti Psychometrics was founded in 1950. |
| Where is Giunti Psychometrics headquartered? | Giunti Psychometrics is headquartered in Italy. |
| Is Giunti Psychometrics publicly listed? | Yes, Giunti Psychometrics is a public company listed on Borsa Italiana. |
| What is the stock symbol of Giunti Psychometrics? | Giunti Psychometrics trades under GPSY ticker. |
| When did Giunti Psychometrics go public? | Giunti Psychometrics went public in 2026. |
| Who are competitors of Giunti Psychometrics? | Giunti Psychometrics main competitors include FamiCord, Concord Medical, Medcorp, Hyperfine, Sudmedica, Clinica de Marly, Emyria, EuroEyes Eye Clinic, Gesundheitswelt Chiemgau, Maternus-Kliniken. |
| What is the current market cap of Giunti Psychometrics? | Giunti Psychometrics' current market cap is $62M. |
| What is the current revenue of Giunti Psychometrics? | Giunti Psychometrics' last fiscal year revenue is $44M. |
| What is the current EV/Revenue multiple of Giunti Psychometrics? | Current revenue multiple of Giunti Psychometrics is 1.6x. |
| Is Giunti Psychometrics profitable? | No, Giunti Psychometrics is not profitable. |
| How many companies Giunti Psychometrics has acquired to date? | Giunti Psychometrics hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Giunti Psychometrics has invested to date? | Giunti Psychometrics hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Giunti Psychometrics
Lists including Giunti Psychometrics
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




